In our January/February issue:
SURVEY SPOTLIGHT
Patient Engagement: Are We There Yet?
Findings from a new ACT and SCORR Marketing survey reveal a gap in the shift to
true patient engagement in clinical trials, but overall measures do signal growth in patient-centric activities.
PEER-REVIEWED ARTICLES
Social Media’s Clinical Impact
Nimita Limaye, PhD, Awani Saraogi
With social media introducing a pragmatic component to clinical trials—and supporting the world of evidence-based medicine—this report examines the growing utility of social media in adverse event reporting and advancing patient-centric initiatives in drug development.
|
The MS Trial Imperative: Reducing Risk
Marie Trad, MD, Cathy Vanbelle, Benjamin Moody, PhD, Amy Del Medico, Olija Tanjga, MD, Sam Khinda, Lynne Hughes, PhD
Despite the market authorization of 16 therapies for multiple sclerosis (MS), there is still no cure for this debilitating disease. Authors explore the key challenges in designing and executing multi-regional clinical trials for MS—and propose mitigation strategies that may help reduce the burden from these associated risks.
|
NEWS
Washington Report: Jill Wechsler on FDA’s goal to maintain momentum in speeding breakthrough drugs to patients.
EU Report: Peter O’Donnell looks at efforts in Europe to improve R&D communication and trust with investors and the public.
Data Management: An expert view on how sponsors can formalize the use of real-world data and generation of real-world evidence to drive critical insights.
|
CISCRP CORNER
Public Clinical Research Literacy: New Insights
CISCRP Research Services: Annick Anderson, Jasmine Benger, Nova Getz
The first series of results from the Center for Information and Study on Clinical Research Participation’s (CISCRP) landmark 2017 Perceptions & Insights Study. |
CLOSING THOUGHT
The Frontier for Dermatology Biologics
Darcee Strube
To vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
|
|
|
If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lisa.henderson@ubm.com
Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.
Click here to contact the Applied Clinical Trials sales team. |
